Literature DB >> 16158054

Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers.

K Maeno1, A Masuda, K Yanagisawa, H Konishi, H Osada, T Saito, R Ueda, T Takahashi.   

Abstract

The c-jun oncogene is frequently overexpressed in non-small-cell lung cancers (NSCLC), but its functional involvement in lung cancer development has not been clearly elucidated. In this study, we found that among the immediate-early serum responsible genes, exemplified by c-jun, c-fos and c-myc, induction of c-jun in a human bronchial epithelial cell line, BEAS-2B, was dependent on anchorage, in contrast to clear induction of c-fos and c-myc under both anchorage-dependent and -independent conditions. In fact, forced expression of c-jun in BEAS-2B cells significantly increased cell viability and colony formation in soft agar. Furthermore, we also found that such anchorage-dependent regulation of c-jun was lost in a significant fraction of human lung cancer cell lines. Interestingly, suppressed anchorage-independent but not anchorage-dependent growth was noted by constitutive expression of a dominant-negative c-jun mutant in a lung cancer cell line showing dysregulated and sustained c-jun expression in the absence of anchorage. These findings suggest that dysregulated c-jun expression may be involved in the acquisition of anchorage independence in the process of human lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16158054     DOI: 10.1038/sj.onc.1209018

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

Review 1.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

2.  Retroviral cyclin controls cyclin-dependent kinase 8-mediated transcription elongation and reinitiation.

Authors:  Claire H Birkenheuer; Connie D Brewster; Sandra L Quackenbush; Joel Rovnak
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.

Authors:  Thomas Hussenet; Soraya Dali; Julien Exinger; Ben Monga; Bernard Jost; Doulaye Dembelé; Nadine Martinet; Christelle Thibault; Joerg Huelsken; Elisabeth Brambilla; Stanislas du Manoir
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

4.  APE1 modulates cellular responses to organophosphate pesticide-induced oxidative damage in non-small cell lung carcinoma A549 cells.

Authors:  Shweta Thakur; Monisha Dhiman; Anil K Mantha
Journal:  Mol Cell Biochem       Date:  2017-09-08       Impact factor: 3.396

5.  Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model.

Authors:  C Escudero-Lourdes; M K Medeiros; M C Cárdenas-González; S M Wnek; J A Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

6.  c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis.

Authors:  Pablo Lopez-Bergami; Hyungsoo Kim; Antimone Dewing; James Goydos; Stuart Aaronson; Ze'ev Ronai
Journal:  J Biol Chem       Date:  2009-11-12       Impact factor: 5.157

Review 7.  Understanding signaling cascades in melanoma.

Authors:  Pablo Lopez-Bergami; Boris Fitchman; Ze'ev Ronai
Journal:  Photochem Photobiol       Date:  2007-12-15       Impact factor: 3.421

8.  c-JUN prevents methylation of p16(INK4a) (and Cdk6): the villain turned bodyguard.

Authors:  Karoline Kollmann; Gerwin Heller; Veronika Sexl
Journal:  Oncotarget       Date:  2011-05

9.  Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.

Authors:  J Kikuchi; I Kinoshita; Y Shimizu; S Oizumi; M Nishimura; M J Birrer; H Dosaka-Akita
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

10.  Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant.

Authors:  Y Shimizu; I Kinoshita; J Kikuchi; K Yamazaki; M Nishimura; M J Birrer; H Dosaka-Akita
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.